Profound Medical Corp. (PROF)
NASDAQ: PROF · IEX Real-Time Price · USD
8.12
-0.03 (-0.37%)
At close: Mar 27, 2024, 12:00 AM
8.01
-0.11 (-1.35%)
After-hours: Mar 27, 2024, 6:35 PM EDT

Profound Medical Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Net Income
-33.38-16.58-30.52-24.42-19.71-20.79-18.82-16.33
Depreciation & Amortization
1.151.61.881.541.511.670.870.19
Share-Based Compensation
3.424.247.213.021.271.091.341
Other Operating Activities
6.52-15.06-0.92-0.711.89-0.261.040.64
Operating Cash Flow
-22.3-25.8-22.36-20.57-15.05-18.29-15.57-14.5
Capital Expenditures
00-0.03000-0.43-0.86
Acquisitions
0000-00.180
Change in Investments
0000-0010
Other Investing Activities
---0.56-0.35-0.19--0.03-0.22
Investing Cash Flow
00-0.59-0.35-0.190-0.288.91
Share Issuance / Repurchase
2.670.266.43103.688.7134.619.0116.19
Debt Issued / Paid
-1.26.77-0.39-9.61-1.2511.6-2.88-0.29
Other Financing Activities
---0.1-6.64-0.87-8.32-0.02-
Financing Cash Flow
1.467.035.9587.436.637.886.1215.9
Net Cash Flow
-20.83-18.77-17.0166.51-8.6419.58-9.7310.31
Free Cash Flow
-22.3-25.8-22.39-20.57-15.05-18.29-16-15.37
Free Cash Flow Margin
-309.72%-386.17%-325.80%-281.68%-360.57%-703.02%-326.26%-
Free Cash Flow Per Share
-1.04-1.24-1.08-1.05-1.27-1.54--
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).